BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230308
DTEND;VALUE=DATE:20230310
DTSTAMP:20260516T052333
CREATED:20221215T131203Z
LAST-MODIFIED:20221215T131251Z
UID:36101-1678233600-1678406399@www.pharmajournalist.com
SUMMARY:Targeted Intracellular Delivery Summit
DESCRIPTION:Achieve Therapeutic Localization with Selective\, Effective & Validated Delivery to Intracellular Targets \nOptimize Your Pipeline’s Therapeutic Index with Novel Delivery Systems to Overcome Endosomal Barriers in Target Cells \nSelective cell entry\, biological barriers and complexities in targeting chemistry have long restricted the ability of promising drug candidates to impactfully engage their intracellular sites of action without off-target toxicity implications. \nFast forward to 2023\, advances in nanomedicine technology\, the LNP enabled mRNA vaccine and emphasis on personalized medicine has triggered significant pipeline shifts towards complex nucleic-acid and biologic candidates. This clinical translation depends on novel delivery systems accessing previously elusive intracellular compartments. This is further evidenced by AstraZeneca\, Boehringer Ingelheim and Eli Lilly’s announcements of prioritized strategic investment in targeted intracellular delivery technologies. \nAt such a pivotal moment for the industry\, the Targeted Intracellular Delivery Summit arrives to bring Formulation\, Chemistry\, Delivery & Biology industry professionals to the forefront of cutting-edge science critical to accelerate pharmaceutical R&D. Join 80+ senior leaders to explore target identification\, tissue delivery\, engineering technologies\, endosomal escape\, delivery validation analytics and more. \nThis is your definitive meeting for unpresented data\, unrivalled insights and unmissable methodologies across the next-generation nano-platforms including LNPs\, EVs\, Liposomes & more\, creating new opportunities for the development of safer and efficacious oligonucleotide\, siRNA\, mRNA\, DNA delivery and protein payloads. \nUnleash the true potential of your pipeline by gaining the best picture of industry’s fast-paced nano-platform progress this March! \nTo know more visit: https://ter.li/i23a5q
URL:https://www.pharmajournalist.com/event/targeted-intracellular-delivery-summit/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR